Fuso Pharmaceutical Industries,Ltd. (TYO:4538)

TYO:4538 Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2013	FY 2012	FY 2011
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011
Net Income	-	-	6,237	6	984
Depreciation & Amortization	-	-	1,750	1,888	2,088
Loss (Gain) From Sale of Assets	-	-	-2,472	26	86
Loss (Gain) From Sale of Investments	-	-	21	-	11
Other Operating Activities	-	-	-14	-30	-37
Change in Accounts Receivable	-	-	-3,170	-401	2,019
Change in Inventory	-	-	-901	-881	984
Change in Accounts Payable	-	-	831	97	-688
Change in Other Net Operating Assets	-	-	976	179	1,497
Operating Cash Flow	-	-	3,258	884	6,944
Operating Cash Flow Growth	-	-	268.55%	-87.27%	217.66%
Capital Expenditures	-	-	-1,928	-1,206	-1,015
Sale of Property, Plant & Equipment	-	-	3,975	-	9
Investment in Securities	-	-	635	-105	-218
Other Investing Activities	-	-	-266	-71	-118
Investing Cash Flow	-	-	2,416	-1,382	-1,342
Short-Term Debt Issued	-	-	-	295	-
Long-Term Debt Issued	-	-	3,270	4,300	2,550
Total Debt Issued	-	-	3,270	4,595	2,550
Short-Term Debt Repaid	-	-	-100	-	-3,435
Long-Term Debt Repaid	-	-	-3,452	-3,104	-3,355
Total Debt Repaid	-	-	-3,552	-3,104	-6,790
Net Debt Issued (Repaid)	-	-	-282	1,491	-4,240
Repurchase of Common Stock	-	-	-5	-3	-8
Common Dividends Paid	-	-	-542	-542	-542
Other Financing Activities	-	-	-3	-3	-2
Financing Cash Flow	-	-	-832	943	-4,792
Foreign Exchange Rate Adjustments	-	-	-	-1	-13
Miscellaneous Cash Flow Adjustments	-	-	-	1	-2
Net Cash Flow	-	-	4,842	445	795
Free Cash Flow	-	-	1,330	-322	5,929
Free Cash Flow Growth	-	-	-	-	484.14%
Free Cash Flow Margin	-	-	2.74%	-0.73%	12.49%
Free Cash Flow Per Share	-	-	146.90	-35.56	654.59
Cash Interest Paid	-	-	261	247	302
Cash Income Tax Paid	-	-	17	44	48
Levered Free Cash Flow	-	-	1,161	-313.13	5,546
Unlevered Free Cash Flow	-	-	1,326	-149.38	5,737
Change in Working Capital	-	-	-2,264	-1,006	3,812

Source: S&P Global Market Intelligence. Standard template. Financial Sources.